Treatment strategies for amyloid A amyloidosis
Authors:
- 31 July 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 9 (12) , 2117-2128
Abstract
(2008). Treatment strategies for amyloid A amyloidosis. Expert Opinion on Pharmacotherapy: Vol. 9, No. 12, pp. 2117-2128.Keywords
This publication has 94 references indexed in Scilit:
- Variant mannose‐binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritisJournal of Internal Medicine, 2007
- Country as the primary risk factor for renal amyloidosis in familial mediterranean feverArthritis & Rheumatism, 2007
- SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritisModern Rheumatology, 2006
- AmyloidosisAnnual Review of Medicine, 2006
- Familial Mediterranean Fever (FMF) in TurkeyMedicine, 2005
- Where has secondary amyloid gone?Annals of the Rheumatic Diseases, 2000
- High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosisArthritis & Rheumatism, 1996
- Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosisAmyloid, 1994
- Amyloidosis and Inflammatory Bowel Disease A 50-Year Experience with 25 PatientsMedicine, 1992
- SERUM AMYLOID-A PROTEIN CONCENTRATION IN INFLAMMATORY DISEASES AND ITS RELATIONSHIP TO THE INCIDENCE OF REACTIVE SYSTEMIC AMYLOIDOSISThe Lancet, 1982